Wick Capital Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $503K | Buy |
21,979
+14,694
| +202% | +$337K | 0.13% | 70 |
|
2025
Q1 | $535K | Sell |
7,285
-687
| -9% | -$50.5K | 0.16% | 63 |
|
2024
Q4 | $522K | Sell |
7,972
-61
| -0.8% | -$4K | 0.15% | 61 |
|
2024
Q3 | $626K | Hold |
8,033
| – | – | 0.2% | 48 |
|
2024
Q2 | $626K | Sell |
8,033
-568
| -7% | -$44.3K | 0.22% | 44 |
|
2024
Q1 | $583K | Hold |
8,601
| – | – | 0.57% | 22 |
|
2023
Q4 | $579K | Sell |
8,601
-19
| -0.2% | -$1.28K | 0.24% | 38 |
|
2023
Q3 | $584K | Sell |
8,620
-15
| -0.2% | -$1.02K | 0.33% | 35 |
|
2023
Q2 | $618K | Buy |
8,635
+32
| +0.4% | +$2.29K | 0.37% | 27 |
|
2023
Q1 | $597K | Sell |
8,603
-180
| -2% | -$12.5K | 0.34% | 33 |
|
2022
Q4 | $595K | Buy |
8,783
+280
| +3% | +$19K | 0.33% | 31 |
|
2022
Q3 | $466K | Sell |
8,503
-383
| -4% | -$21K | 0.3% | 31 |
|
2022
Q2 | $587K | Buy |
+8,886
| New | +$587K | 0.41% | 23 |
|